Matinas Biopharma Holdings Inc.

Last updated September 27, 2026
Favorite this organization

Organization details

Legal name
Matinas Biopharma Holdings Inc.
Ownership
Public
Status
Active
Headquarters country
United States
Ticker symbol
MTNB
Primary stock exchange
NYSE American

Identifiers

SEC CIK
0001582554

Board of directors

Follow this board

Chief executives

Jerome D. Jabbour · President and CEO
Dates unknown

Board connections

8 of this board's directors also sit on 8 other boards.

Network of Matinas Biopharma Holdings Inc.'s board connections Backblaze Inc. Backblaze Inc. Celldex Therapeutics Inc. Celldex Therapeutics I... Celularity Inc. Celularity Inc. Grace Therapeutics Inc. Grace Therapeutics Inc... Indaptus Therapeutics Inc. Indaptus Therapeutics... Marker Therapeutics Inc. Marker Therapeutics In... Oragenics Inc. Oragenics Inc. VivoSim Labs Inc. VivoSim Labs Inc. An Evelyn D. An Evelyn D. Edward Neugeboren Edward Neugeboren Herbert J. Conrad Herbert J. Conrad Jerome D. Jabbour Jerome D. Jabbour Kathryn Penkus Corzo Kathryn Penkus Corzo Keith Murphy Keith Murphy Natasha Giordano Natasha Giordano Robin L. Smith Robin L. Smith Matinas Biopharma Holdings...
Shared director Other board Same sector

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months
$0
0 purchases by 0 insiders
Sold, last 12 months
$0
0 sales by 0 insiders
Date Insider Transaction Shares Price Value
Jul 10, 2026 Adam K. Stern 10% owner In-the-money exercise +344,710 $0.35 $120,649
Jul 10, 2026 Adam K. Stern 10% owner In-the-money exercise +630,335 $0.35 $220,617
Oct 31, 2025 Adam K. Stern 10% owner In-the-money exercise +92,100 $0.64 $59,368

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.